The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> June 28, 2013

Interview with the Founder, CEO & Executive Director: Unilife Corporation (UNIS)

Shortall, Alan
Alan Shortall is the Founder, CEO and Executive Director of Unilife Corporation, a U.S.-based medical device and technology company that designs, develops, manufactures and supplies innovative, differentiated delivery systems for injectable drugs and vaccines. Since 2002, Mr. Shortall has led the growth of the company's products into one of the most diversified portfolios of drug delivery systems, positioning the company to be a global leader in the industry. Mr. Shortall spearheaded the transition of the Australia-founded company into a registered U.S. business listed on the Nasdaq Global Exchange under the symbol UNIS, and it continues to be traded on the Australian Stock Exchange under the symbol UNS. Mr. Shortall is committed to the growth of Unilife Corporation, creating strong shareholder value as well as enhancing and saving the lives of millions worldwide who are at risk from unsafe injection practices. In recognition of his substantial marketing and commercial experience and solid leadership of Unilife Corporation, Mr. Shortall, in 2008, was named to the list of 100 Notable People in the medical device industry by trade magazine Medical Device and Diagnostic Industry, or MD&DI. In January 2010, Mr. Shortall was profiled on the front cover of Drug Delivery Technology magazine.  Profile
TWST: Let's begin with a brief history of Unilife and an overview of your injectable product technologies.

Mr. Shortall: I founded Unilife in 2002. At that stage, we were a safety

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
AI Opportunities Expand to Industrial, Utilities and Energy Sectors
India Fund Manager Expects Discretionary Spending to Grow
Inefficiency in Ex-US Markets Creates Opportunity to Buy at a Discount
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy